Related Experiment Video

Updated: Nov 8, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.9K

Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape

Xueqin Zou1,2, Yangjing Zhao1,2, Xiuting Liang3

  • 1Reproductive Sciences Institute, Jiangsu University, Zhenjiang, China.

Frontiers in Immunology
|April 19, 2021
PubMed

Insights

MicroRNAs (miRNAs) are key players in ovarian cancer (OC) progression, mediating both platinum drug resistance and immune evasion. Understanding these roles offers new therapeutic strategies for this deadly gynecological malignancy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer (OC) remains a leading cause of gynecological cancer mortality.
  • Immune escape and platinum drug resistance significantly contribute to OC progression, recurrence, and poor patient outcomes.

Purpose of the Study:

  • To review recent studies on microRNAs (miRNAs) in OC platinum resistance.
  • To systematically analyze the role of miRNAs in regulating OC immune escape.

Main Methods:

  • Literature review of scientific studies.
  • Systematic analysis of miRNA involvement in platinum resistance and immune escape mechanisms in OC.

Main Results:

  • MicroRNAs (miRNAs) are implicated in regulating gene expression at the transcriptional level.
  • Evidence highlights crucial roles of miRNAs in both platinum resistance and tumor immune escape in OC.

Conclusions:

  • Further understanding of miRNA mechanisms in platinum resistance and immune escape is essential.
  • Targeting miRNAs may offer novel therapeutic avenues for improving OC treatment outcomes.
Keywords:
chemoresistancecisplatinimmune escapemiRNAovarian cancerplatinum

More Related Videos

A Proximal Culture Method to Study Paracrine Signaling Between Cells08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

9.7K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.5K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K